astragaloside a has been researched along with Alzheimer Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Gao, F; Wang, J; Wang, X; Xu, W; Zhu, G | 1 |
Bade, R; Bao, M; Borjigidai, A; Cheng, Y; Liu, H; Shao, G; Tsambaa, B | 1 |
Chen, F; Cheng, XY; Li, J; Liu, HT; Wang, R; Yang, D; Yang, H; Yang, XH; Yao, Y; Zheng, P | 1 |
Alves, RD; Cavalcante, JS; Cavalcanti, JRLP; Costa, IM; Fernandes, LCB; Filho, IA; Freire, MAM; Guzen, FP; Lima, FOV; Lucena, EES; Neta, FI; Norrara, B; Queiroz, DB; Rego, ACM | 1 |
Ma, Y; Xiong, L | 1 |
Cui, Y; Hu, JP; Li, BK; Ren, L; Wang, X; Wang, Y; Yu, S; Zhang, LD | 1 |
Liang, P; Zhao, XM; Zhou, NN; Zhu, R | 1 |
1 review(s) available for astragaloside a and Alzheimer Disease
Article | Year |
---|---|
Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review.
Topics: Alzheimer Disease; Animals; Brain Ischemia; Encephalomyelitis; Humans; Nervous System Diseases; Neuroprotective Agents; Parkinson Disease; Saponins; Triterpenes | 2019 |
6 other study(ies) available for astragaloside a and Alzheimer Disease
Article | Year |
---|---|
Depichering the Effects of Astragaloside IV on AD-Like Phenotypes: A Systematic and Experimental Investigation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astragalus propinquus; Computational Biology; Disease Models, Animal; Drugs, Chinese Herbal; Hippocampus; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Network Pharmacology; Neuroinflammatory Diseases; Peptide Fragments; Phenotype; Phosphorylation; Phytotherapy; PPAR gamma; Pyroptosis; Saponins; Signal Transduction; Support Vector Machine; tau Proteins; Triterpenes | 2021 |
Astragaloside IV against Alzheimer's disease via microglia-mediated neuroinflammation using network pharmacology and experimental validation.
Topics: Alzheimer Disease; ErbB Receptors; Humans; Inflammation; Microglia; Molecular Docking Simulation; Network Pharmacology; Neuroinflammatory Diseases; Proto-Oncogene Proteins c-bcl-2; Saponins; Triterpenes | 2023 |
Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Aβ Induced Alzheimer's Disease Mouse Model via Inhibition of Microglial Activation and NADPH Oxidase Expression.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astragalus Plant; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Drugs, Chinese Herbal; Hippocampus; Male; Maze Learning; Mice, Inbred ICR; Microglia; NADP; NADPH Oxidases; Neuroinflammatory Diseases; Neurons; Neuroprotective Agents; Phytotherapy; Reactive Oxygen Species; Saponins; Triterpenes | 2021 |
Astragaloside IV ameliorates endoplasmic reticulum stress‑induced apoptosis of Aβ25‑35‑treated PC12 cells by inhibiting the p38 MAPK signaling pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cell Survival; Disease Models, Animal; Endoplasmic Reticulum Stress; Humans; Malondialdehyde; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Peptide Fragments; Rats; Reactive Oxygen Species; Saponins; Signal Transduction; Superoxide Dismutase; Triterpenes | 2019 |
Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cell Line, Tumor; Genes, Reporter; Humans; Ligands; Luciferases; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Amyloid; Plasmids; PPAR gamma; Presenilin-1; Response Elements; Saponins; Transfection; Triterpenes | 2017 |
[Effect and mechanism of traditional Chinese herbs against Aβ expression in brain tissues of mice with Alzheimer's disease].
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Benzyl Alcohols; Brain; Disease Models, Animal; Glucosides; Hippocampus; Memory; Mice; Mice, Transgenic; Monoterpenes; Plaque, Amyloid; Random Allocation; Saponins; Triterpenes | 2016 |